Open Access
Ann Toxicol Anal
Volume 20, Numéro 1, 2008
Page(s) 17 - 24
Publié en ligne 6 juin 2008
  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs, Federal Register. 2004. Consulté sur le site le 27 septembre 2007. [Google Scholar]
  2. Baden LR, Horowitz G, Jacoby H, Eliopoulos GM. Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA. 2001; 286(24): 3115-3119. [CrossRef] [PubMed] [Google Scholar]
  3. Melanson SE, Lee-Lewandrowski E, Griggs DA, Long WH, Flood JG. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays. Arch Pathol Lab Med. 2006; 130(12): 1834-1838. [PubMed] [Google Scholar]
  4. Dasgupta A, Wells A, Datta P. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine. Ther Drug Monit. 2007; 29(1): 134-139. [CrossRef] [PubMed] [Google Scholar]
  5. Iwersen-Bergmann S, Schmoldt A. Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA DAU urine immunoassays. J Anal Toxicol. 1999; 23(4): 247-256. [CrossRef] [PubMed] [Google Scholar]
  6. Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Morland J. Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci Int. 1990; 44(2-3): 179-185. [CrossRef] [PubMed] [Google Scholar]
  7. Asselin WM, Leslie JM, McKinley B. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays. J Anal Toxicol. 1988; 12(4): 207-215. [CrossRef] [PubMed] [Google Scholar]
  8. Bogusz M, Aderjan R, Schmitt G, Nadler E, Neureither B. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays–a comparative study. Forensic Sci Int. 1990; 48(1): 27-37. [CrossRef] [PubMed] [Google Scholar]
  9. Lewellen LJ, McCurdy HH. A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT). J Anal Toxicol. 1988; 12(5): 260-264. [CrossRef] [PubMed] [Google Scholar]
  10. Asselin WM, Leslie JM. Modification of Emit assay reagents for improved sensitivity and cost effectiveness in the analysis of hemolyzed whole blood. J Anal Toxicol. 1992; 16(6): 381-388. [CrossRef] [PubMed] [Google Scholar]
  11. Hino Y, Ojanpera I, Rasanen I, Vuori E. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic Sci Int. 2003; 131(2-3): 148-155. [CrossRef] [PubMed] [Google Scholar]
  12. Cagle JC, McCurdy HH, Pan YM, Ayton KJ, Wall WH, Solomons ET. Evaluation of the CEDIA DAU assays and the AxSym system for the analysis of cannabinoids in whole blood. J Anal Toxicol. 1997; 21(3): 213-217. [CrossRef] [PubMed] [Google Scholar]
  13. Gaillard Y, Pépin G, Marquet P, Kintz P, Deveaux M, Mura P. Identification et dosage de la benzoylecgonine, cocaine, méthylecgonine-ester, codéine, morphine et 6-acétylmorphine dans le sang total. Toxicorama. 1996; 8(2): 17-22. [Google Scholar]
  14. Kintz P, Cirimele V, Pépin G, Marquet P, Deveaux M, Mura P. Identification et dosage des cannabinoides dans le sang total. Toxicorama. 1996; 8(2): 29-33. [Google Scholar]
  15. Marquet P, Lachâtre G, Kintz P, Pépin G, Deveaux M, Mura P. Identification et dosage des principales drogues amphétaminiques dans le sang total par chromatographie en phase gazeuse couplée à la spectrométrie de masse (CPG-SM). Toxicorama. 1996; 8(2): 23-28. [Google Scholar]
  16. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh el O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem. 2005; 51(7): 1165-1176. [CrossRef] [PubMed] [Google Scholar]
  17. Eichorst J. beta-Phenethylamine causes false positive amphetamines in post mortem specimens when tested by SYVA EMIT. Forensic Sci Int. 1991; 50(1): 139-40. [CrossRef] [PubMed] [Google Scholar]
  18. Kroener L, Musshoff F, Madea B. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD. J Anal Toxicol. 2003; 27(4): 205-212. [CrossRef] [PubMed] [Google Scholar]